Springer Nature
Browse
13058_2018_1083_MOESM5_ESM.docx (16.41 kB)

Additional file 5: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Download (16.41 kB)
journal contribution
posted on 2018-12-10, 05:00 authored by Jennifer Brooks, Elizabeth Comen, Anne Reiner, Irene Orlow, Siok Leong, Xiaolin Liang, Lene MellemkjĂŚr, Julia Knight, Charles Lynch, Esther John, Leslie Bernstein, Meghan Woods, David Doody, Kathleen Malone, Jonine Bernstein
Association between tamoxifen treatment and risk of CBC stratified by CYP2D6 activity score in Caucasian women in the WECARE Study population (DOCX 16 kb)

Funding

National Cancer Institute

History

Usage metrics

    Breast Cancer Research

    Categories

    Keywords

    Contralateral breast cancerTamoxifenCYP2D6

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC